BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83:1575-8. [PMID: 15866611 DOI: 10.1016/j.fertnstert.2004.11.051] [Cited by in Crossref: 136] [Cited by in F6Publishing: 111] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Feig DS, Moses RG. Metformin therapy during pregnancy: good for the goose and good for the gosling too? Diabetes Care 2011;34:2329-30. [PMID: 21949224 DOI: 10.2337/dc11-1153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
2 Langer O. Oral hypoglycemic agents: do the ends justify the means? Matern Health Neonatol Perinatol 2015;1:19. [PMID: 27057336 DOI: 10.1186/s40748-015-0021-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Hutson JR, Garcia-Bournissen F, Davis A, Koren G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther. 2011;90:67-76. [PMID: 21562489 DOI: 10.1038/clpt.2011.66] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 10.5] [Reference Citation Analysis]
4 Pollex EK, Feig DS, Koren G. Oral hypoglycemic therapy: Understanding the mechanisms of transplacental transfer. The Journal of Maternal-Fetal & Neonatal Medicine 2010;23:224-8. [DOI: 10.3109/14767050903550881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
5 Banaszewska B, Pawelczyk L, Spaczynski R. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome. Reproductive Biology 2019;19:309-15. [DOI: 10.1016/j.repbio.2019.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Klieger C, Pollex E, Koren G. Treating the mother – protecting the unborn: The safety of hypoglycemic drugs in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 2009;21:191-6. [DOI: 10.1080/14767050801929653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Tertti K, Toppari J, Virtanen HE, Sadov S, Rönnemaa T. Metformin Treatment Does Not Affect Testicular Size in Offspring Born to Mothers with Gestational Diabetes. Rev Diabet Stud 2016;13:59-65. [PMID: 26859658 DOI: 10.1900/RDS.2016.13.59] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
8 Lalic-popovic M, Paunkovic J, Grujic Z, Golocorbin-kon S, Milasinovic L, Al-salami H, Mikov M. Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes: 头孢呋辛在合并糖尿病的孕妇胎盘中以及跨细胞渗透都减少了. Journal of Diabetes 2016;8:238-45. [DOI: 10.1111/1753-0407.12288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 . ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131:e49-64. [PMID: 29370047 DOI: 10.1097/AOG.0000000000002501] [Cited by in Crossref: 384] [Cited by in F6Publishing: 148] [Article Influence: 96.0] [Reference Citation Analysis]
10 Nguyen L, Chan SY, Teo AKK. Metformin from mother to unborn child - Are there unwarranted effects? EBioMedicine. 2018;35:394-404. [PMID: 30166273 DOI: 10.1016/j.ebiom.2018.08.047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
11 Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N. Pharmacotherapy for gestational diabetes. Expert Opin Pharmacother 2018;19:1407-14. [PMID: 30136869 DOI: 10.1080/14656566.2018.1509955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kovo M, Haroutiunian S, Feldman N, Hoffman A, Glezerman M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008;136:29-33. [DOI: 10.1016/j.ejogrb.2007.01.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
13 Liong S, Lappas M. Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes. PLoS One 2015;10:e0122633. [PMID: 25849717 DOI: 10.1371/journal.pone.0122633] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
14 Cheung NW. The management of gestational diabetes. Vasc Health Risk Manag. 2009;5:153-164. [PMID: 19436673 DOI: 10.2147/vhrm.s3405] [Cited by in Crossref: 46] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
15 Simmons D. Safety considerations with pharmacological treatment of gestational diabetes mellitus. Drug Saf 2015;38:65-78. [PMID: 25542297 DOI: 10.1007/s40264-014-0253-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
16 Tarry-Adkins JL, Aiken CE, Ozanne SE. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. PLoS Med 2020;17:e1003126. [PMID: 32442232 DOI: 10.1371/journal.pmed.1003126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
17 Greger HK, Hanem LGE, Østgård HF, Vanky E. Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT. BMC Pediatr 2020;20:60. [PMID: 32039724 DOI: 10.1186/s12887-020-1960-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Finneran MM, Landon MB. Oral Agents for the Treatment of Gestational Diabetes. Curr Diab Rep 2018;18. [DOI: 10.1007/s11892-018-1093-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Tavares RS, Escada-rebelo S, Silva AF, Sousa MI, Ramalho-santos J, Amaral S. Antidiabetic therapies and male reproductive function: where do we stand? Reproduction 2018;155:R13-37. [DOI: 10.1530/rep-17-0390] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
20 Faure M, Bertoldo MJ, Khoueiry R, Bongrani A, Brion F, Giulivi C, Dupont J, Froment P. Metformin in Reproductive Biology. Front Endocrinol (Lausanne) 2018;9:675. [PMID: 30524372 DOI: 10.3389/fendo.2018.00675] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
21 Griffith RJ, Alsweiler J, Moore AE, Brown S, Middleton P, Shepherd E, Crowther CA. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2020;6:CD012394. [PMID: 32526091 DOI: 10.1002/14651858.CD012394.pub3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
22 He K, Guo Q, Ge J, Li J, Li C, Jing Z. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials. J Clin Pharm Ther 2021. [PMID: 34363237 DOI: 10.1111/jcpt.13503] [Reference Citation Analysis]
23 Simmons D. Metformin treatment for Type 2 diabetes in pregnancy? Best Practice & Research Clinical Endocrinology & Metabolism 2010;24:625-34. [DOI: 10.1016/j.beem.2010.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
24 Gregg B, Elghazi L, Alejandro EU, Smith MR, Blandino-Rosano M, El-Gabri D, Cras-Méneur C, Bernal-Mizrachi E. Exposure of mouse embryonic pancreas to metformin enhances the number of pancreatic progenitors. Diabetologia 2014;57:2566-75. [PMID: 25249235 DOI: 10.1007/s00125-014-3379-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
25 Rø TB, Ludvigsen HV, Carlsen SM, Vanky E. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest 2012;72:570-5. [PMID: 22935043 DOI: 10.3109/00365513.2012.712319] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
26 Desai N, Roman A, Rochelson B, Gupta M, Xue X, Chatterjee PK, Tam Tam H, Metz CN. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. Am J Obstet Gynecol 2013;209:136.e1-9. [PMID: 23659985 DOI: 10.1016/j.ajog.2013.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
27 Deng J, Mueller M, Geng T, Shen Y, Liu Y, Hou P, Mamillapalli R, Taylor HS, Paidas M, Huang Y. H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses. Cell Death Dis 2017;8:e3175. [PMID: 29215608 DOI: 10.1038/cddis.2017.392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
28 Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, Cui YM. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol 2015;80:1224-34. [PMID: 25925501 DOI: 10.1111/bcp.12672] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
29 Kalra B, Gupta Y, Singla R, Kalra S. Use of oral anti-diabetic agents in pregnancy: a pragmatic approach. N Am J Med Sci 2015;7:6-12. [PMID: 25709972 DOI: 10.4103/1947-2714.150081] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
30 Hanem LGE, Salvesen Ø, Juliusson PB, Carlsen SM, Nossum MCF, Vaage MØ, Ødegård R, Vanky E. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health 2019;3:166-74. [PMID: 30704873 DOI: 10.1016/S2352-4642(18)30385-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
31 Coustan DR. Gestational diabetes mellitus. Clin Chem 2013;59:1310-21. [PMID: 23536513 DOI: 10.1373/clinchem.2013.203331] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 11.9] [Reference Citation Analysis]
32 Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Diab Rep 2009;9:287-90. [DOI: 10.1007/s11892-009-0044-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
33 Zhen XM, Li X, Chen C. Metformin versus insulin for gestational diabetes: The reporting of ethnicity and a meta-analysis combining English and Chinese literatures. Obesity Medicine 2018;11:48-58. [DOI: 10.1016/j.obmed.2018.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
34 Salomäki H, Vähätalo LH, Laurila K, Jäppinen NT, Penttinen AM, Ailanen L, Ilyasizadeh J, Pesonen U, Koulu M. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS One 2013;8:e56594. [PMID: 23457588 DOI: 10.1371/journal.pone.0056594] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
35 Vanky E, Carlsen SM. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns. Fertility and Sterility 2012;97:509-515.e1. [DOI: 10.1016/j.fertnstert.2011.11.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
36 Zhang Y, Liu X, Yang L, Zou L. Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy. Front Pharmacol 2020;11:596145. [PMID: 33381040 DOI: 10.3389/fphar.2020.596145] [Reference Citation Analysis]
37 Lee N, Hebert MF, Wagner DJ, Easterling TR, Liang CJ, Rice K, Wang J. Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during Pregnancy. Mol Pharmacol 2018;94:1125-31. [PMID: 30012584 DOI: 10.1124/mol.118.112482] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
38 Keely E. Type 2 diabetes in pregnancy: importance of optimized care before, during and after pregnancy. Obstet Med 2008;1:72-7. [PMID: 27582789 DOI: 10.1258/om.2008.080007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Koning SH, Hoogenberg K, Lutgers HL, van den Berg PP, Wolffenbuttel BH. Gestational Diabetes Mellitus:current knowledge and unmet needs. J Diabetes 2016;8:770-81. [PMID: 27121958 DOI: 10.1111/1753-0407.12422] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
40 Bolnick A, Abdulhasan M, Kilburn B, Xie Y, Howard M, Andresen P, Shamir AM, Dai J, Puscheck EE, Rappolee DA. Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos. J Assist Reprod Genet 2016;33:1027-39. [PMID: 27230877 DOI: 10.1007/s10815-016-0735-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
41 Miranda JO, Cerqueira RJ, Ramalho C, Areias JC, Henriques-Coelho T. Fetal Cardiac Function in Maternal Diabetes: A Conventional and Speckle-Tracking Echocardiographic Study. J Am Soc Echocardiogr 2018;31:333-41. [PMID: 29246511 DOI: 10.1016/j.echo.2017.11.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
42 Vidigal CB, Novi DRBS, Moura KF, Picinin R, Montagnini BG, Silva RNOD, da Silva MDV, de Andrade FG, Akamine EH, Gerardin DCC, Ceravolo GS. Intrauterine exposure to metformin: Evaluation of endothelial and perivascular adipose tissue function in abdominal aorta of adult offspring. Life Sci 2018;207:72-9. [PMID: 29852188 DOI: 10.1016/j.lfs.2018.05.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Li C, Gao C, Zhang X, Zhang L, Shi H, Jia X. Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials. Gynecol Endocrinol 2021;:1-7. [PMID: 34907818 DOI: 10.1080/09513590.2021.2015761] [Reference Citation Analysis]
44 van Weelden W, Wekker V, de Wit L, Limpens J, Ijäs H, van Wassenaer-Leemhuis AG, Roseboom TJ, van Rijn BB, DeVries JH, Painter RC. Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs. Diabetes Ther 2018;9:1811-29. [PMID: 30168045 DOI: 10.1007/s13300-018-0479-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
45 Verduci E, Calcaterra V, Di Profio E, Fiore G, Rey F, Magenes VC, Todisco CF, Carelli S, Zuccotti GV. Brown Adipose Tissue: New Challenges for Prevention of Childhood Obesity. A Narrative Review. Nutrients 2021;13:1450. [PMID: 33923364 DOI: 10.3390/nu13051450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrinol Metab Clin North Am 2019;48:479-93. [PMID: 31345518 DOI: 10.1016/j.ecl.2019.05.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
47 Feig DS, Briggs GG, Koren G. Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift? Ann Pharmacother 2007;41:1174-80. [DOI: 10.1345/aph.1k045] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
48 Diav-citrin O, Steinmetz-shoob S, Shechtman S, Ornoy A. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study. Reproductive Toxicology 2018;80:85-91. [DOI: 10.1016/j.reprotox.2018.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S232-43. [PMID: 34964864 DOI: 10.2337/dc22-S015] [Reference Citation Analysis]
50 Kurosawa K, Chiba K, Noguchi S, Nishimura T, Tomi M. Development of a Pharmacokinetic Model of Transplacental Transfer of Metformin to Predict In Vivo Fetal Exposure. Drug Metab Dispos 2020;48:1293-302. [PMID: 33051249 DOI: 10.1124/dmd.120.000127] [Reference Citation Analysis]
51 Cheung NW, Mcelduff A, Ross GP. Type 2 diabetes in pregnancy: a wolf in sheep's clothing. Aust N Z J Obstet Gynaecol 2005;45:479-83. [DOI: 10.1111/j.1479-828x.2005.00480.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
52 Feigel ML, Kennard A, Lannaman K. Herbalism for Modern Obstetrics. Clin Obstet Gynecol 2021;64:611-34. [PMID: 34323236 DOI: 10.1097/GRF.0000000000000637] [Reference Citation Analysis]
53 Meroni SB, Galardo MN, Rindone G, Gorga A, Riera MF, Cigorraga SB. Molecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation. Front Endocrinol (Lausanne) 2019;10:224. [PMID: 31040821 DOI: 10.3389/fendo.2019.00224] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 20.7] [Reference Citation Analysis]
54 Hegerty CK. The new gestational diabetes: Treatment, evidence and consent. Aust N Z J Obstet Gynaecol 2020;60:482-5. [PMID: 32506466 DOI: 10.1111/ajo.13116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Forcato S, Novi DRBDS, Costa NO, Borges LI, Góes MLMD, Ceravolo GS, Gerardin DCC. In utero and lactational exposure to metformin induces reproductive alterations in male rat offspring. Reproductive Toxicology 2017;74:48-58. [DOI: 10.1016/j.reprotox.2017.08.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
56 Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update 2014;20:656-69. [PMID: 24861556 DOI: 10.1093/humupd/dmu022] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 9.9] [Reference Citation Analysis]
57 Legro RS. Metformin during pregnancy in polycystic ovary syndrome: another vitamin bites the dust. J Clin Endocrinol Metab 2010;95:5199-202. [PMID: 21131540 DOI: 10.1210/jc.2010-2301] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
58 Tartarin P, Moison D, Guibert E, Dupont J, Habert R, Rouiller-fabre V, Frydman N, Pozzi S, Frydman R, Lecureuil C, Froment P. Metformin exposure affects human and mouse fetal testicular cells. Human Reproduction 2012;27:3304-14. [DOI: 10.1093/humrep/des264] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
59 Liao MZ, Flood Nichols SK, Ahmed M, Clark S, Hankins GD, Caritis S, Venkataramanan R, Haas D, Quinney SK, Haneline LS, Tita AT, Manuck T, Wang J, Thummel KE, Brown LM, Ren Z, Easterling TR, Hebert MF. Effects of Pregnancy on the Pharmacokinetics of Metformin. Drug Metab Dispos 2020;48:264-71. [PMID: 31980499 DOI: 10.1124/dmd.119.088435] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
60 Ma'ayeh M, Rood KM, Kniss D, Costantine MM. Novel Interventions for the Prevention of Preeclampsia. Curr Hypertens Rep 2020;22:17. [PMID: 32052203 DOI: 10.1007/s11906-020-1026-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
61 Lautatzis M, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review. Metabolism 2013;62:1522-34. [DOI: 10.1016/j.metabol.2013.06.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
62 . Practice Bulletin No. 180: Gestational Diabetes Mellitus. Obstetrics & Gynecology 2017;130:e17-37. [DOI: 10.1097/aog.0000000000002159] [Cited by in Crossref: 102] [Cited by in F6Publishing: 44] [Article Influence: 20.4] [Reference Citation Analysis]
63 Tertti K, Laine K, Ekblad U, Rinne V, Rönnemaa T. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus. Acta Diabetol 2014;51:731-8. [DOI: 10.1007/s00592-014-0570-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
64 Symonds ME, Aldiss P, Dellschaft N, Law J, Fainberg HP, Pope M, Sacks H, Budge H. Brown adipose tissue development and function and its impact on reproduction. Journal of Endocrinology 2018;238:R53-62. [DOI: 10.1530/joe-18-0084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
65 Hanem LGE, Stridsklev S, Júlíusson PB, Salvesen Ø, Roelants M, Carlsen SM, Ødegård R, Vanky E. Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs. J Clin Endocrinol Metab 2018;103:1612-21. [PMID: 29490031 DOI: 10.1210/jc.2017-02419] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 19.5] [Reference Citation Analysis]
66 Romero R, Erez O, Hüttemann M, Maymon E, Panaitescu B, Conde-Agudelo A, Pacora P, Yoon BH, Grossman LI. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol 2017;217:282-302. [PMID: 28619690 DOI: 10.1016/j.ajog.2017.06.003] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 22.4] [Reference Citation Analysis]
67 Carlsen S, Vanky E. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns. Human Reproduction 2010;25:786-90. [DOI: 10.1093/humrep/dep444] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
68 Hu J, Zhang J, Zhu B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol 2019;33:649-58. [PMID: 31334867 DOI: 10.1111/fcp.12501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
69 Ala M, Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? ACS Pharmacol Transl Sci 2021;4:1747-70. [PMID: 34927008 DOI: 10.1021/acsptsci.1c00167] [Reference Citation Analysis]
70 Hart R. Generational Health Impact of PCOS on Women and their Children. Med Sci (Basel) 2019;7:E49. [PMID: 30889922 DOI: 10.3390/medsci7030049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
71 Tertti K, Eskola E, Rönnemaa T, Haataja L. Neurodevelopment of Two-Year-Old Children Exposed to Metformin and Insulin in Gestational Diabetes Mellitus. Journal of Developmental & Behavioral Pediatrics 2015;36:752-7. [DOI: 10.1097/dbp.0000000000000230] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
72 Tertti K, Ekblad U, Heikkinen T, Rahi M, Rönnemaa T, Laine K. The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. European Journal of Pharmaceutical Sciences 2010;39:76-81. [DOI: 10.1016/j.ejps.2009.10.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
73 Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, Barrett JFR, Karanicolas PJ, Tobin S, McIntyre HD, Tian SY, Tomlinson G, Murphy KE; MiTy Collaborative Group. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2020;8:834-44. [PMID: 32946820 DOI: 10.1016/S2213-8587(20)30310-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
74 Hosni A, El-Twab SA, Abdul-Hamid M, Prinsen E, AbdElgawad H, Abdel-Moneim A, Beemster GTS. Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress. Pharmacol Res 2021;165:105426. [PMID: 33453370 DOI: 10.1016/j.phrs.2021.105426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 de Oliveira Baraldi C, Lanchote VL, de Jesus Antunes N, de Jesus Ponte Carvalho TM, Dantes Moisés EC, Duarte G, Cavalli RC. Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome. Eur J Clin Pharmacol 2011;67:1027-33. [DOI: 10.1007/s00228-011-1053-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
76 Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Hankins GD, Ahmed MS. Transfer of metformin across the dually perfused human placental lobule. American Journal of Obstetrics and Gynecology 2006;195:1081-5. [DOI: 10.1016/j.ajog.2006.05.047] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
77 Mao W, Zhang S, Wang L, Shen S. Efficacy and safety of metformin in the treatment of gestational diabetes: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e23954. [PMID: 33429755 DOI: 10.1097/MD.0000000000023954] [Reference Citation Analysis]
78 Nayak G, Salian SR, Agarwal P, Suresh Poojary P, Rao A, Kumari S, Kalthur SG, Shreya AB, Mutalik S, Adiga SK, Kalthur G. Antidiabetic drug metformin affects the developmental competence of cleavage-stage embryos. J Assist Reprod Genet 2020;37:1227-38. [PMID: 32335799 DOI: 10.1007/s10815-020-01709-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Raperport C, Chronopoulou E, Homburg R. Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome. Expert Rev Endocrinol Metab 2021;16:37-47. [PMID: 33634727 DOI: 10.1080/17446651.2021.1889366] [Reference Citation Analysis]
80 Helseth R, Vanky E, Stridsklev S, Vogt C, Carlsen SM. Maternal and fetal insulin levels at birth in women with polycystic ovary syndrome: data from a randomized controlled study on metformin. European Journal of Endocrinology 2014;170:769-75. [DOI: 10.1530/eje-13-0859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
81 Garbarino VR, Santos TA, Nelson AR, Zhang WQ, Smolik CM, Javors MA, Daws LC, Gould GG. Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice. Pharmacol Res 2019;140:21-32. [PMID: 30423430 DOI: 10.1016/j.phrs.2018.11.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RPV. Randomized trial of metformin vs insulin in the management of gestational diabetes. American Journal of Obstetrics and Gynecology 2013;209:34.e1-7. [DOI: 10.1016/j.ajog.2013.03.022] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 9.1] [Reference Citation Analysis]
83 Ryu RJ, Hays KE, Hebert MF. Gestational diabetes mellitus management with oral hypoglycemic agents. Semin Perinatol 2014;38:508-15. [PMID: 25315294 DOI: 10.1053/j.semperi.2014.08.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
84 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Reference Citation Analysis]
85 Owen MD, Baker BC, Scott EM, Forbes K. Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. Int J Mol Sci 2021;22:5759. [PMID: 34071182 DOI: 10.3390/ijms22115759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Forcato S, Montagnini BG, de Góes MLM, da Silva Novi DRB, Inhasz Kiss AC, Ceravolo GS, Ceccatto Gerardin DC. Reproductive evaluations in female rat offspring exposed to metformin during intrauterine and intrauterine/lactational periods. Reprod Toxicol 2019;87:1-7. [PMID: 31055052 DOI: 10.1016/j.reprotox.2019.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
87 Kintiraki E, Goulis DG. Gestational diabetes mellitus: Multi-disciplinary treatment approaches. Metabolism 2018;86:91-101. [PMID: 29627447 DOI: 10.1016/j.metabol.2018.03.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
88 Tertti K, Ekblad U, Koskinen P, Vahlberg T, Rönnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246-51. [DOI: 10.1111/dom.12017] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 7.6] [Reference Citation Analysis]
89 Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, Clark SM, Risler L, Wang J, Kelly EJ, Shen DD, Hebert MF. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 2010;38:833-40. [PMID: 20118196 DOI: 10.1124/dmd.109.031245] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 9.2] [Reference Citation Analysis]
90 Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009;30:1-50. [PMID: 19056992 DOI: 10.1210/er.2008-0030] [Cited by in Crossref: 235] [Cited by in F6Publishing: 209] [Article Influence: 16.8] [Reference Citation Analysis]
91 Feghali MN, Umans JG, Catalano PM. Drugs to Control Diabetes During Pregnancy. Clin Perinatol 2019;46:257-72. [PMID: 31010559 DOI: 10.1016/j.clp.2019.02.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Bahri Khomami M, Boyle JA, Tay CT, Vanky E, Teede HJ, Joham AE, Moran LJ. Polycystic ovary syndrome and adverse pregnancy outcomes: Current state of knowledge, challenges and potential implications for practice. Clin Endocrinol (Oxf) 2018;88:761-9. [PMID: 29460303 DOI: 10.1111/cen.13579] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
93 Given JE, Loane M, Garne E, Addor MC, Bakker M, Bertaut-Nativel B, Gatt M, Klungsoyr K, Lelong N, Morgan M, Neville AJ, Pierini A, Rissmann A, Dolk H. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ 2018;361:k2477. [PMID: 29941493 DOI: 10.1136/bmj.k2477] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
94 Paavilainen E, Tertti K, Nikkinen H, Veijola R, Vääräsmäki M, Loo BM, Tossavainen P, Rönnemaa T, Niinikoski H. Metformin versus insulin therapy for gestational diabetes: Effects on offspring anthropometrics and metabolism at the age of 9 years: A follow-up study of two open-label, randomized controlled trials. Diabetes Obes Metab 2021. [PMID: 34738701 DOI: 10.1111/dom.14589] [Reference Citation Analysis]
95 Coustan DR. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care 2013;36:777-9. [PMID: 23520369 DOI: 10.2337/dc12-2505] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
96 Pollex EK, Hutson JR. Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents. Expert Opinion on Drug Metabolism & Toxicology 2011;7:325-39. [DOI: 10.1517/17425255.2011.553188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
97 Dearden L, Bouret SG, Ozanne SE. Nutritional and developmental programming effects of insulin. J Neuroendocrinol 2021;33:e12933. [PMID: 33438814 DOI: 10.1111/jne.12933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Nüsken E, Turnwald EM, Fink G, Voggel J, Yosy C, Kretschmer T, Handwerk M, Wohlfarth M, Weber LT, Hucklenbruch-Rother E, Dötsch J, Nüsken KD, Appel S. Maternal High Fat Diet and in-Utero Metformin Exposure Significantly Impact upon the Fetal Renal Proteome of Male Mice. J Clin Med 2019;8:E663. [PMID: 31083566 DOI: 10.3390/jcm8050663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
99 Mukerji G, Feig DS. Pharmacological Management of Gestational Diabetes Mellitus. Drugs 2017;77:1723-32. [DOI: 10.1007/s40265-017-0807-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
100 Dickens LT, Thomas CC. Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1147-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
101 Zhuo Z, Wang A, Yu H. Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Diabetes Res 2014;2014:381231. [PMID: 24963493 DOI: 10.1155/2014/381231] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
102 Ijäs H, Vääräsmäki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG: Int J Obstet Gy 2015;122:994-1000. [DOI: 10.1111/1471-0528.12964] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
103 Ayas B, Kırmızıkan S, Kocaman A, Avcı B. The effects of metformin treatment on the ovaries and uterus of offspring. Gynecol Endocrinol 2021;37:624-8. [PMID: 32930027 DOI: 10.1080/09513590.2020.1819002] [Reference Citation Analysis]
104 Hufnagel A, Fernandez-Twinn DS, Blackmore HL, Ashmore TJ, Heaton RA, Jenkins B, Koulman A, Hargreaves IP, Aiken CE, Ozanne SE. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. J Physiol 2021. [PMID: 34505282 DOI: 10.1113/JP281902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Xu Q, Xie Q. Long-term effects of prenatal exposure to metformin on the health of children based on follow-up studies of randomized controlled trials: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;299:1295-303. [PMID: 30953188 DOI: 10.1007/s00404-019-05124-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
106 Kovo M, Kogman N, Ovadia O, Nakash I, Golan A, Hoffman A. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn 2008;28:544-8. [PMID: 18509858 DOI: 10.1002/pd.2026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
107 Salvesen KA, Vanky E, Carlsen SM. Metformin treatment in pregnant women with polycystic ovary syndrome--is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound Obstet Gynecol 2007;29:433-7. [PMID: 17330831 DOI: 10.1002/uog.3965] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
108 Garcia-Contreras C, Vazquez-Gomez M, Pesantez-Pacheco JL, Heras-Molina A, Encinas T, Astiz S, Gonzalez-Bulnes A. The Effects of Maternal Metformin Treatment on Late Prenatal and Early Postnatal Development of the Offspring Are Modulated by Sex. Pharmaceuticals (Basel) 2020;13:E363. [PMID: 33158193 DOI: 10.3390/ph13110363] [Reference Citation Analysis]
109 Bertoldo MJ, Faure M, Dupont J, Froment P. Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation. Ann Transl Med 2014;2:55. [PMID: 25333030 DOI: 10.3978/j.issn.2305-5839.2014.06.04] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
110 Singh N, Madhu M, Vanamail P, Malik N, Kumar S. Efficacy of metformin in improving glycaemic control & perinatal outcome in gestational diabetes mellitus: A non-randomized study. Indian J Med Res 2017;145:623-8. [PMID: 28948952 DOI: 10.4103/ijmr.IJMR_1358_15] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
111 Langer O. Pharmacological treatment of gestational diabetes mellitus: point/counterpoint. Am J Obstet Gynecol 2018;218:490-9. [PMID: 29499921 DOI: 10.1016/j.ajog.2018.01.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
112 Szukiewicz D, Szewczyk G, Pyzlak M, Stangret A, Bachanek M, Trojanowski S, Alkhalayla H, Wejman J. Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments. Inflammation 2018;41:2246-64. [PMID: 30097812 DOI: 10.1007/s10753-018-0867-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
113 Koufakis T, Garas A, Zebekakis P, Kotsa K. Non-insulin agents for the management of gestational diabetes: lack of evidence versus lack of action. Expert Opin Pharmacother 2021;:1-3. [PMID: 34165014 DOI: 10.1080/14656566.2021.1942842] [Reference Citation Analysis]
114 Maymone AC, Baillargeon JP, Ménard J, Ardilouze JL. Oral hypoglycemic agents for gestational diabetes mellitus? Expert Opin Drug Saf 2011;10:227-38. [PMID: 21210750 DOI: 10.1517/14740338.2011.521740] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
115 Hedrington MS, Davis SN. The care of pregestational and gestational diabetes and drug metabolism considerations. Expert Opin Drug Metab Toxicol 2017;13:1029-38. [PMID: 28847172 DOI: 10.1080/17425255.2017.1372423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]